Interestingly, Xu et al. found that KCNN4 could boost the progression of lung adenocarcinoma by synchronously activating the AKT and ERK signaling pathways [19], which granted their studies certain similarity and repeatability. Here, AKT1 is linked to lung adenocarcinoma.